,9 While establishing drug association is challenging, our patient was initiated on pembrolizumab, a programmed cell death ligand 1 inhibitor, followed by nivolumab, a PD-1 inhibitor, which may have contributed to direct ICI-induced TEN. This evidence concerns the gene CD274 and toxic epidermal necrolysis.